Noble Patents AI Sound Detection to Verify Medical Device Usage
The new technology uses neural networks to verify correct drug delivery and diagnostic device usage via acoustic signatures.
Noble, an Aptar Pharma company, has been granted a U.S. patent for an AI-enabled system designed to detect, analyze, and classify sound output from diagnostic and drug delivery devices. Announced on August 12, 2026, the technology provides a method for objectively verifying that critical steps in device operation have been completed correctly.
The patented system employs time-series acoustic sensing combined with neural network-based machine learning to recognize specific sound signatures associated with device use. According to company documentation, this approach allows for objective feedback on device operation without the need for hardware modifications or the addition of visual markers. By analyzing the acoustic profile of a device, the system can determine if a patient or clinician has operated the tool as intended.
The Shift to Home Care
This development comes as medical therapies increasingly move toward home-based administration and self-care. As patients take on more responsibility for managing complex drug delivery and diagnostic tools, the risk of user error increases. Ensuring that these devices are used with precision is critical for both patient safety and the overall efficacy of the treatment. Noble’s focus on patient-centered solutions aims to mitigate these risks by providing a digital layer of verification during the administration process.
Impact on Usability and Safety
By utilizing sound rather than physical hardware changes, the technology can be integrated into existing device ecosystems more seamlessly. This provides a non-invasive way to conduct human factors evaluations, usability studies, and patient training. For the industry, this means a more accurate way to identify where users struggle with device interfaces, allowing manufacturers to refine designs based on objective acoustic data rather than subjective user reports.
A Broader AI Strategy
This patent is not an isolated project but part of a comprehensive AI strategy at Aptar. The company is integrating artificial intelligence across multiple domains, including digital health solutions, quality prediction, formulation and product development, and analytical and compatibility testing. Aptar is also leveraging AI for advanced data analytics and gaining deeper patient and consumer insights to inform future device iterations.
As the healthcare industry continues to digitize, the focus will likely shift toward how these acoustic verification systems can be scaled across different device types and integrated into broader remote patient monitoring platforms.